So Far, So Good for PCSK9-Targeting Gene Therapy in Hypercholesterolemia

(MedPage Today) -- An investigational gene therapy passed muster for reducing PCSK9 and LDL cholesterol levels, with reassuring safety, among patients with heterozygous familial hypercholesterolemia (HeFH) or premature coronary artery disease ...
Source
MedPage Today
Opens original article in a new tab



